Compare LEXX & BWEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEXX | BWEN |
|---|---|---|
| Founded | 2004 | N/A |
| Country | Canada | United States |
| Employees | N/A | 341 |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7M | 100.5M |
| IPO Year | 2011 | 2009 |
| Metric | LEXX | BWEN |
|---|---|---|
| Price | $3.19 | $4.22 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.83 |
| AVG Volume (30 Days) | 82.6K | ★ 151.1K |
| Earning Date | 07-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 360.00 |
| EPS | N/A | ★ N/A |
| Revenue | $705,923.00 | ★ $146,785,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $6,915.00 | $4.14 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 52.05 | N/A |
| 52 Week Low | $0.35 | $1.88 |
| 52 Week High | $14.37 | $5.70 |
| Indicator | LEXX | BWEN |
|---|---|---|
| Relative Strength Index (RSI) | 35.47 | 46.01 |
| Support Level | $0.57 | $4.10 |
| Resistance Level | $12.89 | $4.15 |
| Average True Range (ATR) | 0.51 | 0.17 |
| MACD | -0.12 | 0.01 |
| Stochastic Oscillator | 25.92 | 55.56 |
Lexaria Bioscience Corp is a biotechnology company focused on enhancing the bioavailability of active pharmaceutical ingredients using its patented DehydraTECH drug delivery technology. DehydraTECH improves absorption, effectiveness, and tolerability and can be applied to APIs such as GLP-1 and GIP drugs, vitamins, pain medications, hormones, antivirals, nicotine and cannabinoids across therapeutic areas including diabetes, weight loss, epilepsy, hypertension, and heart disease. It can be used in formats such as tablets, capsules, oral suspensions, foods, beverages, and pouches, and supports pharmaceuticals, nutraceuticals, over-the-counter products, and consumer packaged goods. The Company operates one segment: IP licensing, generating revenue from licensing its DehydraTECH technology.
Broadwind Inc is a precision manufacturer of structures, equipment, and components for clean technology and other specialized applications. The company provides technologically high-value products to customers with complex systems and stringent quality standards that operate in the energy, mining, and infrastructure sectors in the United States of America. Its capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treatment, CNG decompression, precision machining, assembly, engineering, and packaging solutions, among others. The company operates in four reportable segments: Heavy Fabrications, which generates the maximum revenue, Gearing, Industrial Solutions, and Corporate.